HudaSalmanMD

PubMed

• Targeting Interleukin-13 Receptor α2 and EphA2 in Aggressive Breast Cancer Subtypes with Special References to Chimeric Antigen Receptor T-Cell Therapy.
  Dharambir Kashyap, Huda Salman> ;International Journal of Molecular Sciences. 2024 Mar 28
• 4 citations
  Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
  Fatemeh Ardeshir-Larijani, Bryan P Schneider, Sandra K Althouse, Milan Radovich, Ashiq Masood, Fabiana Perna, Huda Salman, Patrick J Loehrer> ;JCO Precision Oncology. 2023 Feb 1
• 2 citations
  Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare?
  Rita Assi, Huda Salman> ;Cells. 2022 Dec 8
• 14 citations
  Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: a multicen...
  John M Pagel, Jacob D Soumerai, Nishitha Reddy, Deepa Jagadeesh, Anastasios Stathis, Adam Asch, Huda Salman, Vaishalee P Kenkre, Alexia Iasonos, Judith Llorin-Sangalan...> ;The Lancet. Oncology. 2022 Aug 1
• 4 citations
  Sphingolipids in Hematopoiesis: Exploring Their Role in Lineage Commitment.
  Yasharah Raza, Huda S. Salman, Chiara Luberto> ;Cells. 2021 Sep 22
• 51 citations
  Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of internation...
  Amer M. Zeidan, Prajwal C. Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal, Rory M. Shallis, David P. Steensma, Michael R. Savona,...> ;The Lancet. Haematology. 2020 Aug 1
• 24 citations
  Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells.
  Huda S. Salman, Kevin G. Pinz, Masayuki Wada, Xiao Shuai, Lulu E. Yan, Jessica C. Petrov, Yupo Ma> ;Journal of Cancer. 2019 Jul 23
• 2 citations
  Intracranial acute promyelocytic leukemia at presentation-A case-based discussion.
  Kristin Sticco, Tahmeena Ahmed, Huda S. Salman> ;Leukemia Research Reports. 2019 Jan 1
• 75 citations
  Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia
  Jessica C. Petrov, Masayuki Wada, Kevin G. Pinz, Lulu E. Yan, Kevin Chen, Xiao Shuai, Hua Liu, Xi Chen, Lai Han Leung, Huda S. Salman, Nabil Hagag, Fang Liu, Xun Jiang...> ;Leukemia. 2018 Feb 25
• 55 citations
  A compound chimeric antigen receptor strategy for targeting multiple myeloma.
  Kevin Chen, Masayuki Wada, Kevin G. Pinz, Hua Liu, Xiao Shuai, Xi Chen, Lulu E. Yan, Jessica C. Petrov, Huda S. Salman, Lisa Senzel, Elaine Lai-Han Leung, Xun Jiang, Y...> ;Leukemia. 2018 Feb 1
• 7 citations
  Anti-CD19 chimeric antigen receptor targeting of CD19 + acute myeloid leukemia.
  Gina Ma, Yi Wang, Tahmeena Ahmed, Ann Leslie Zaslav, Laura Hogan, Cecilia Avila, Masayuki Wada, Huda S. Salman> ;Leukemia Research Reports. 2018 Jan 1
• 9 citations
  SALL1 expression in acute myeloid leukemia
  Huda S Salman, Xiao Shuai, Anh Thu Nguyen-Lefebvre, Banabihari Giri, Mingqiang Ren, Michael Rauchman, Lynn Robbins, Wei Hou, Hasan Korkaya, Yupo Ma> ;Oncotarget. 2017 Dec 15
• 73 citations
  Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells.
  Kevin G. Pinz, Elizabeth Yakaboski, Alexander Jares, Hua Liu, Amelia E. Firor, Kevin Chen, Masayuki Wada, Huda S. Salman, William Tse, Nabil Hagag, Fengshuo Lan, Elain...> ;Oncotarget. 2017 Nov 22
• 131 citations
  Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
  Kevin Chen, Masayuki Wada, Kevin G. Pinz, Hua Liu, K. W. Lin, Alexander Jares, Amelia E. Firor, Xiao Shuai, Huda S. Salman, Marc G. Golightly, Fengshuo Lan, L. Senzel,...> ;Leukemia. 2017 Jan 12
• 52 citations
  A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML, or AML with ⩽ 30% blasts.
  G. Garcia-Manero, Mikkael A. Sekeres, Miklos Egyed, Massimo Breccia, Carlos Graux, James D. Cavenagh, Huda Salman, Árpád Illés, Pierre Fenaux, Daniel J. DeAngelo, Rein...> ;Leukemia. 2017 May 26
• 87 citations
  Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies.
  Kevin Chen, Masayuki Wada, Amelia E. Firor, Kevin G. Pinz, Alexander Jares, Hua Liu, Huda S. Salman, Marc G. Golightly, Fengshuo Lan, Xun Jiang, Yupo Ma> ;Oncotarget. 2016 Aug 2
• 3 citations
  A case of lymphoproliferative disorder of NK-cells: aggressive immunophenotype but indolent behavior.
  Min Shi, Natasha M. Savage, Huda Salman, William G. Morice> ;Clinical Case Reports. 2015 Sep 1
• 17 citations
  RPPA-based protein profiling reveals eIF4G overexpression and 4E-BP1 serine 65 phosphorylation as molecular events that correspond with a pro-survival phenotype in chr...
  Austin Y. Shull, Satish Noonepalle, Farrukh T. Awan, Jimei Liu, Lirong Pei, Roni J. Bollag, Huda Salman, Zhiyong Ding, Huidong Shi> ;Oncotarget. 2015 May 12
• 49 citations
  Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cells
  Xiaoyun Lu, Zhi-Chun Ding, Yang Cao, Chufeng Liu, Tsadik Habtetsion, Miao Yu, Henrique Lemos, Huda Salman, Hongyan Xu, Andrew L. Mellor, Gang Zhou> ;Journal of Immunology. 2015 Feb 15
• 5 citations
  Administration of anti-thymocyte globulin: a comparison of two protocols.
  Amber B. Clemmons, Megan E Hartranft, Vamsi Kota, Jeremy Pantin, Farrukh T. Awan, Huda Salman, Anand Jillella> ;Bone Marrow Transplantation. 2014 Dec 11
• 3 citations
  Plerixafor for autologous CD34 cell mobilization.
  Huda S. Salman, Hillard M. Lazarus> ;Core Evidence. 2011 Feb 8
• 1 citations
  Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma.
  Huda S. Salman, Alejandra Perez, Joseph A. Sparano, Howard Ratech, Abdissa Negassa, Una Hopkins, Gina M. Villani, Joachim Z. Fuks, Peter H. Wiernik> ;American Journal of Clinical Oncology. 2003 Aug 1
• 38 citations
  Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver.
  Huda S. Salman, Jacov Cynamon, Marci Jagust, Curtis W. Bakal, Alla M. Rozenblit, Ron Kaleya, Abdissa Negassa, Scott Wadler> ;Clinical Colorectal Cancer. 2002 Nov 1
• 6 citations
  Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanes
  Huda S. Salman, Katie Tanaka, Joseph A. Sparano> ;Clinical Breast Cancer. 2002 Jan 1
• Join now to see all

Journal Articles

• SALL1 expression in acute myeloid leukemia  
  iao Shuai,2,3,* Anh Thu Nguyen-Lefebvre,1,* Banabihari Giri,1 Mingqiang Ren,1 Michael Rauchman,4 Lynn Robbins,4 Wei Hou,2 Hasan Korkaya,1 and Yupo Ma2, Oncotarget, 1/26/2018